Literature DB >> 21677131

Cecal ligation and puncture-induced impairment of innate immune function does not occur in the absence of caspase-1.

E D Murphey1.   

Abstract

Mice that have been subjected to cecal ligation and puncture (CLP) have an impaired ability to clear a subsequent Pseudomonas aeruginosa challenge compared with that of sham CLP controls. We hypothesized that this outcome is dependent upon a caspase-1 mechanism and tested this hypothesis by measuring caspase-1 after CLP and by measuring clearance of a bacterial challenge in caspase-1-deficient mice after CLP. Wild-type mice subjected to CLP had increased caspase-1 activity as well as increased IL-1β and increased IL-18 production in splenocytes stimulated with heat-killed Pseudomonas and had increased plasma concentrations of IL-1β and IL-18 and impaired clearance of a P. aeruginosa challenge compared with sham controls. Healthy, uninjured caspase-1(-\-) mice did not differ from wild-type mice in their ability to clear a Pseudomonas challenge. However, unlike wild-type mice, caspase-1(-/-) mice subjected to CLP had no impairment of bacterial clearance of the Pseudomonas challenge, suggesting that caspase-1 induction after CLP played a role in impairment of bacterial clearance. This was further substantiated by the use of a specific caspase-1 inhibitor, Ac-YVAD-CMK. Wild-type mice treated with Ac-YVAD-CMK (10 mg/kg s.c. twice daily, initiated at time of CLP) did not have impaired clearance of a Pseudomonas challenge compared with that of sham mice and had significantly improved bacterial clearance compared with that of untreated CLP mice. Increased caspase-1 expression and activity after CLP injury appears to contribute to diminished innate immune function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677131      PMCID: PMC3131453          DOI: 10.4049/jimmunol.1002102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Injury, sepsis, and the regulation of Toll-like receptor responses.

Authors:  Thomas J Murphy; Hugh M Paterson; John A Mannick; James A Lederer
Journal:  J Leukoc Biol       Date:  2003-10-13       Impact factor: 4.962

Review 2.  Physiological functions of caspases beyond cell death.

Authors:  Thomas Q Nhan; W Conrad Liles; Stephen M Schwartz
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.

Authors:  R S Hotchkiss; K C Chang; P E Swanson; K W Tinsley; J J Hui; P Klender; S Xanthoudakis; S Roy; C Black; E Grimm; R Aspiotis; Y Han; D W Nicholson; I E Karl
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

4.  Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf.

Authors:  Edward A Miao; Celia M Alpuche-Aranda; Monica Dors; April E Clark; Martin W Bader; Samuel I Miller; Alan Aderem
Journal:  Nat Immunol       Date:  2006-04-30       Impact factor: 25.606

5.  Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression.

Authors:  E D Murphey; Cheng Y Lin; Roy W McGuire; Tracy Toliver-Kinsky; David N Herndon; Edward R Sherwood
Journal:  Shock       Date:  2004-05       Impact factor: 3.454

6.  The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

Authors:  Guillaume Monneret; Marie-Emmanuelle Finck; Fabienne Venet; Anne-Lise Debard; Julien Bohé; Jacques Bienvenu; Alain Lepape
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

7.  Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients.

Authors:  Thomas Murphy; Hugh Paterson; Selwyn Rogers; John A Mannick; James A Lederer
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

Review 8.  Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target?

Authors:  A Oberholzer; C Oberholzer; R M Minter; L L Moldawer
Journal:  Immunol Lett       Date:  2001-01-15       Impact factor: 3.685

9.  Characterization and modulation of the immunosuppressive phase of sepsis.

Authors:  Jared T Muenzer; Christopher G Davis; Kathy Chang; Robert E Schmidt; W Michael Dunne; Craig M Coopersmith; Richard S Hotchkiss
Journal:  Infect Immun       Date:  2010-01-25       Impact factor: 3.441

Review 10.  Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases.

Authors:  Fabio Martinon; Jürg Tschopp
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

View more
  2 in total

1.  Improved emergency myelopoiesis and survival in neonatal sepsis by caspase-1/11 ablation.

Authors:  Lori F Gentile; Angela L Cuenca; Alex G Cuenca; Dina C Nacionales; Ricardo Ungaro; Philip A Efron; Lyle L Moldawer; Shawn D Larson
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

2.  Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages.

Authors:  Xionghui Ding; Hiroto Kambara; Rongxia Guo; Apurva Kanneganti; Maikel Acosta-Zaldívar; Jiajia Li; Fei Liu; Ting Bei; Wanjun Qi; Xuemei Xie; Wenli Han; Ningning Liu; Cunling Zhang; Xiaoyu Zhang; Hongbo Yu; Li Zhao; Fengxia Ma; Julia R Köhler; Hongbo R Luo
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.